Patents by Inventor Gordon Moore Allan

Gordon Moore Allan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for use in treating rotavirus infection
    Patent number: 11344523
    Abstract: The present invention relates to a composition comprising at least one carboxylic acid selected from butanoic acid, hexanoic acid, octanoic acid, decanoic acid, and dodecanoic acid for use in treating a viral infection. Also disclosed is use of a composition comprising at least one carboxylic acid selected from butanoic acid, hexanoic acid, octanoic acid, decanoic acid, and dodecanoic acid in the manufacture of a medicament for treating a viral infection; and a method for treating a viral infection in a subject.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: May 31, 2022
    Assignee: Devenish Nutrition Limited
    Inventors: Violet Emma Beattie, Gordon Moore Allan, Andrena Millar, John Paul McKillen
  • Composition for Use in Treating Rotavirus Infection
    Publication number: 20200222350
    Abstract: The present invention relates to a composition comprising at least one carboxylic acid selected from butanoic acid, hexanoic acid, octanoic acid, decanoic acid, and dodecanoic acid for use in treating a viral infection. Also disclosed is use of a composition comprising at least one carboxylic acid selected from butanoic acid, hexanoic acid, octanoic acid, decanoic acid, and dodecanoic acid in the manufacture of a medicament for treating a viral infection; and a method for treating a viral infection in a subject.
    Type: Application
    Filed: March 23, 2020
    Publication date: July 16, 2020
    Inventors: Violet Emma BEATTIE, Gordon MOORE ALLAN, Andrena MILLAR, John Paul MCKILLEN
  • COMPOSITION FOR USE IN TREATING ROTAVIRUS INFECTION
    Publication number: 20190216760
    Abstract: The present invention relates to a composition comprising at least one carboxylic acid selected from butanoic acid, hexanoic acid, octanoic acid, decanoic acid, and dodecanoic acid for use in treating a viral infection. Also disclosed is use of a composition comprising at least one carboxylic acid selected from butanoic acid, hexanoic acid, octanoic acid, decanoic acid, and dodecanoic acid in the manufacture of a medicament for treating a viral infection; and a method for treating a viral infection in a subject.
    Type: Application
    Filed: June 30, 2017
    Publication date: July 18, 2019
    Inventors: Violet Emma BEATTIE, Gordon MOORE ALLAN, Andrena MILLAR, John Paul MCKILLEN
  • Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
    Patent number: 7211379
    Abstract: Provided is a method for reducing viral load of porcine circovirus type 2 (PCV-2) in a pig by inducing an immune response against PCV-2 through the administration of an immunogenic composition comprising a PCV-2 antigen. A preferred antigen is a vector containing a PCV-2 nucleotide sequence. In a particularly preferred embodiment, the PCV-2 nucleotide sequence is ORF4, ORF13, or ORF4 and ORF13. In some embodiments, the immunogenic composition includes one or more additional pig pathogens.
    Type: Grant
    Filed: February 17, 2004
    Date of Patent: May 1, 2007
    Assignee: Merial SAS
    Inventors: John Ellis, Gordon Moore Allan, Brian Meehan, Edward Clark, Deborah Haines, Lori Hassard, John Harding, Catherine Elisabeth Charreyre, Gilles Emile Chappuis, George Steve Krakowka, Jean-Christophe Francis Audonnet, Francis McNeilly
  • Porcine circovirus and parvovirus vaccine
    Patent number: 6953581
    Abstract: The invention relates to antigenic preparations and vaccines directed against the porcine multisystemic wasting syndrome (PMWS), comprising at least one porcine circovirus antigen, preferably type II, and at least one porcine parvovirus antigen.
    Type: Grant
    Filed: February 16, 2001
    Date of Patent: October 11, 2005
    Assignee: Merial Limited
    Inventors: Gordon Moore Allan, Brian Martin Meehan, John Albert Ellis, George Steven Krakowka, Jean-ChrJistophe Francis Audonnet
  • Porcine circovirus and parvovirus vaccine
    Publication number: 20020146431
    Abstract: The invention relates to antigenic preparations and vaccines directed against the porcine multisystemic wasting syndrome (PMWS), comprising at least one porcine circovirus antigen, preferably type II, and at least one porcine parvovirus antigen.
    Type: Application
    Filed: February 16, 2001
    Publication date: October 10, 2002
    Inventors: Gordon Moore Allan, Brian Martin Meehan, John Albert Ellis, George Steven Krakowka, Jean-Christophe Francis Audonnet
  • Porcine circovirus and paravovirus vaccine
    Patent number: 6217883
    Abstract: The invention relates to antigenic preparations and vaccines directed against the porcine multisystemic wasting syndrome (PMWS), comprising at least one porcine circovirus antigen, preferably type II, and at least one porcine parvovirus antigen.
    Type: Grant
    Filed: July 1, 1999
    Date of Patent: April 17, 2001
    Assignees: Merial, The Queen's University of Belfast, University of Saskatchewan
    Inventors: Gordon Moore Allan, Brian Martin Meehan, John Albert Ellis, George Steven Krakowka, Jean-ChrJistophe Francis Audonnet